We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$19.6B
AUM Growth
+$1.29B
Cap. Flow
+$10.1M
Cap. Flow %
0.05%
Top 10 Hldgs %
29.33%
Holding
681
New
30
Increased
359
Reduced
247
Closed
34

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$346M
2
ZTS icon
Zoetis
ZTS
+$215M
3
ATW
Atwood Oceanics
ATW
+$128M
4
MPC icon
Marathon Petroleum
MPC
+$126M
5
AGI icon
Alamos Gold
AGI
+$112M

Sector Composition

Rank Sector Weight
1 Materials 44.97%
2 Energy 26.85%
3 Industrials 4.46%
4 Healthcare 4.41%
5 Consumer Staples 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
126
GE Aerospace
GE
$374B
$18.2M 0.09%
158,941
+49,678
+45% +$5.7M
BRK.B icon
127
Berkshire Hathaway Class B
BRK.B
$1.1T
$18.2M 0.09%
160,231
+52,397
+49% +$6.04M
CHRW icon
128
C.H. Robinson
CHRW
$17.4B
$18.2M 0.09%
304,659
+86,047
+39% +$5.05M
CSX icon
129
CSX Corp
CSX
$93.4B
$18.1M 0.09%
+2,113,236
New +$17.7M
MDT icon
130
Medtronic
MDT
$109B
$18.1M 0.09%
+339,062
New +$18.2M
KO icon
131
Coca-Cola
KO
$377B
$17.9M 0.09%
+472,601
New +$18.7M
SQM icon
132
Sociedad Química y Minera de Chile
SQM
$19.2B
$17.8M 0.09%
596,728
-92,209
-13% -$2.88M
BNY
133
Bank of New York Mellon
BNY
$106B
$17.7M 0.09%
585,273
+164,655
+39% +$5.05M
PCYC
134
DELISTED
PHARMACYCLICS INC
PCYC
$17.5M 0.09%
126,617
-10,110
-7% -$1.12M
PTEN icon
135
Patterson-UTI
PTEN
$3.98B
$17.4M 0.09%
812,361
-169,945
-17% -$3.49M
PFE icon
136
Pfizer
PFE
$143B
$17.3M 0.09%
636,454
-174,832
-22% -$4.76M
NBR icon
137
Nabors Industries
NBR
$1.27B
$17.1M 0.09%
21,355
-16,942
-44% -$13.3M
ESRX
138
DELISTED
Express Scripts Holding Company
ESRX
$17.1M 0.09%
276,810
+76,814
+38% +$4.97M
GORO icon
139
Goldgroup Mining Inc.
GORO
$157M
$16.5M 0.08%
2,494,467
+181,431
+8% +$1.44M
TDW icon
140
Tidewater
TDW
$3.73B
$16.2M 0.08%
8,465
-1,900
-18% -$3.54M
TLK icon
141
Telkom Indonesia
TLK
$14.5B
$16M 0.08%
879,890
-300,108
-25% -$6.26M
LNN icon
142
Lindsay Corp
LNN
$1.13B
$15.9M 0.08%
195,247
-30,009
-13% -$2.35M
VALE icon
143
Vale
VALE
$64.1B
$15.9M 0.08%
1,018,763
-1,567
-0.2% -$23.2K
RIO icon
144
Rio Tinto
RIO
$158B
$15.5M 0.08%
318,562
+930
+0.3% +$43.4K
ASML icon
145
ASML
ASML
$626B
$14.7M 0.07%
148,447
-12,748
-8% -$1.15M
WOLF icon
146
Wolfspeed
WOLF
$1.23B
$14.6M 0.07%
242,143
+26,217
+12% +$1.67M
NLY icon
147
Annaly Capital Management
NLY
$17.1B
$14.2M 0.07%
307,251
-34,300
-10% -$1.61M
ANR
148
DELISTED
Alpha Natural Resources Inc
ANR
$13.9M 0.07%
2,328,791
+36,400
+2% +$213K
INCY icon
149
Incyte
INCY
$24.2B
$13.8M 0.07%
362,935
+78,870
+28% +$2.33M
PZG icon
150
Paramount Gold Nevada
PZG
$96.1M
$13.5M 0.07%
10,491,851
+1,465,163
+16% +$2.03M

Similar funds

VanEck Associates's Q3 2013 Portfolio in Review

As of Q3 2013, VanEck Associates held 681 positions worth $19.6B, up 7.1% from $18.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

VanEck Associates's Q3 2013 filing shows 30 new, 359 increased, 247 reduced and 34 closed positions. Its largest new stake was Zoetis: 7,013,962 shares worth $218M. The largest sale was KUBOTA CORPORATION (ONE ADS REP 5 SHS COM), an estimated $255M.

By sector, the portfolio is most concentrated in Materials at 45% of assets, down from 45% a quarter earlier, followed by Energy and Industrials.

  • VanEck Associates's largest Q3 2013 buy was Zoetis: 7,013,962 shares worth $218M.
  • VanEck Associates added most to Franco-Nevada in Q3 2013, an estimated $346M increase.
  • VanEck Associates's biggest Q3 2013 reduction was Ensco Rowan plc, cutting an estimated $106M.
  • VanEck Associates fully exited KUBOTA CORPORATION (ONE ADS REP 5 SHS COM) in Q3 2013, selling an estimated $255M.
  • VanEck Associates's ten largest holdings make up 29% of its $19.6B portfolio in Q3 2013.
  • VanEck Associates opened 30 new positions and closed 34 in Q3 2013.
  • VanEck Associates's portfolio value rose 7.1% quarter-over-quarter to $19.6B.

Based on VanEck Associates's 13F filing for Q3 2013, filed 14 Nov 2013.